1887

Journal of General Virology header logo

Volume 91, Issue 9

Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins Free

Abstract

The latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus functions as an origin-binding protein (OBP) and transcriptional regulator. LANA binds the terminal repeats via the C-terminal DNA-binding domain (DBD) to support latent DNA replication. To date, the structure of LANA has not been solved. Sequence alignments among OBPs of gammaherpesviruses have revealed that the C terminus of LANA is structurally related to EBNA1, the OBP of Epstein–Barr virus. Based on secondary structure predictions for LANA and published structures of EBNA1, this study used bioinformatics tools to model a putative structure for LANA bound to DNA. To validate the predicted model, 38 mutants targeting the most conserved motifs, namely three -helices and a conserved proline loop, were constructed and functionally tested. In agreement with data for EBNA1, residues in helices 1 and 2 mainly contributed to sequence-specific DNA binding and replication activity, whilst mutations in helix 3 affected replication activity and multimer formation. Additionally, several mutants were isolated with discordant phenotypes, which may aid further studies into LANA function. In summary, these data suggest that the secondary and tertiary structures of LANA and EBNA1 DBDs are conserved and are critical for (i) sequence-specific DNA binding, (ii) multimer formation, (iii) LANA-dependent transcriptional repression, and (iv) DNA replication.

  • Received:
  • Accepted:
  • Published Online:
© SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.020958-0
2010-09-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/9/2203.html?itemId=/content/journal/jgv/10.1099/vir.0.020958-0&mimeType=html&fmt=ahah

References

  1. Ballestas, M. E. & Kaye, K. M.(2001). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75, 3250–3258.[CrossRef] [Google Scholar]
  2. Ballestas, M. E., Chatis, P. A. & Kaye, K. M.(1999). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641–644.[CrossRef] [Google Scholar]
  3. Barbera, A. J., Chodaparambil, J. V., Kelley-Clarke, B., Joukov, V., Walter, J. C., Luger, K. & Kaye, K. M.(2006). The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311, 856–861.[CrossRef] [Google Scholar]
  4. Bates, P. A., Kelley, L. A., MacCallum, R. M. & Sternberg, M. J.(2001). Enhancement of protein modeling by human intervention in applying the automatic programs 3d-jigsaw and 3d-pssm. Proteins (Suppl. 5), 39–46. [Google Scholar]
  5. Bochkarev, A., Barwell, J. A., Pfuetzner, R. A., Furey, W., Jr, Edwards, A. M. & Frappier, L.(1995). Crystal structure of the DNA-binding domain of the Epstein–Barr virus origin-binding protein EBNA 1. Cell 83, 39–46.[CrossRef] [Google Scholar]
  6. Bochkarev, A., Barwell, J. A., Pfuetzner, R. A., Bochkareva, E., Frappier, L. & Edwards, A. M.(1996). Crystal structure of the DNA-binding domain of the Epstein–Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84, 791–800.[CrossRef] [Google Scholar]
  7. Burnside, K. L., Ryan, J. T., Bielefeldt-Ohmann, H., Bruce, A. G., Thouless, M. E., Tsai, C. & Rose, T. M.(2006). RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells. Virology 354, 103–115.[CrossRef] [Google Scholar]
  8. Ceccarelli, D. F. & Frappier, L.(2000). Functional analyses of the EBNA1 origin DNA binding protein of Epstein–Barr virus. J Virol 74, 4939–4948.[CrossRef] [Google Scholar]
  9. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. & Knowles, D. M.(1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332, 1186–1191.[CrossRef] [Google Scholar]
  10. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. & Moore, P. S.(1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865–1869.[CrossRef] [Google Scholar]
  11. Cotter, M. A. & Robertson, E. S.(1999). The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264, 254–264.[CrossRef] [Google Scholar]
  12. Cruickshank, J., Shire, K., Davidson, A. R., Edwards, A. M. & Frappier, L.(2000). Two domains of the Epstein–Barr virus origin DNA-binding protein, EBNA1, orchestrate sequence-specific DNA binding. J Biol Chem 275, 22273–22277.[CrossRef] [Google Scholar]
  13. de Prat-Gay, G., Gaston, K. & Cicero, D. O.(2008). The papillomavirus E2 DNA binding domain. Front Biosci 13, 6006–6021. [Google Scholar]
  14. Fiser, A. & Sali, A.(2003). ModLoop: automated modeling of loops in protein structures. Bioinformatics 19, 2500–2501.[CrossRef] [Google Scholar]
  15. Fujita, T., Ikeda, M., Kusano, S., Yamazaki, M., Ito, S., Obayashi, M. & Yanagi, K.(2001). Amino acid substitution analyses of the DNA contact region, two amphipathic α-helices and a recognition-helix-like helix outside the dimeric β-barrel of Epstein–Barr virus nuclear antigen 1. Intervirology 44, 271–282.[CrossRef] [Google Scholar]
  16. Gao, S. J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J., Newton, R., Rinaldo, C. R., Saah, A. & other authors(1996). KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2, 925–928.[CrossRef] [Google Scholar]
  17. Garber, A. C., Shu, M. A., Hu, J. & Renne, R.(2001). DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75, 7882–7892.[CrossRef] [Google Scholar]
  18. Garber, A. C., Hu, J. & Renne, R.(2002). Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem 277, 27401–27411.[CrossRef] [Google Scholar]
  19. Grossman, S. R. & Laimins, L. A.(1996). EBNA1 and E2: a new paradigm for origin-binding proteins? Trends Microbiol 4, 87–89.[CrossRef] [Google Scholar]
  20. Grundhoff, A. & Ganem, D.(2003). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J Virol 77, 2779–2783.[CrossRef] [Google Scholar]
  21. Hantz, S., Couvreux, A., Champier, G., Trapes, L., Cotin, S., Denis, F., Bouaziz, S. & Alain, S.(2009). Conserved domains and structure prediction of human cytomegalovirus UL27 protein. Antivir Ther 14, 663–672. [Google Scholar]
  22. Hass, M., Lelke, M., Busch, C., Becker-Ziaja, B. & Gunther, S.(2008). Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome. J Virol 82, 10207–10217.[CrossRef] [Google Scholar]
  23. Havranek, J. J., Duarte, C. M. & Baker, D.(2004). A simple physical model for the prediction and design of protein–DNA interactions. J Mol Biol 344, 59–70.[CrossRef] [Google Scholar]
  24. Hegde, R. S., Grossman, S. R., Laimins, L. A. & Sigler, P. B.(1992). Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359, 505–512.[CrossRef] [Google Scholar]
  25. Hirt, B.(1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26, 365–369.[CrossRef] [Google Scholar]
  26. Hu, J., Garber, A. C. & Renne, R.(2002). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76, 11677–11687.[CrossRef] [Google Scholar]
  27. Kedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J. & Ganem, D.(1996). The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2, 918–924. (erratum: Nat Med(1996). 2, 1041) [Google Scholar]
  28. Kelley-Clarke, B., Ballestas, M. E., Srinivasan, V., Barbera, A. J., Komatsu, T., Harris, T. A., Kazanjian, M. & Kaye, K. M.(2007). Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding. J Virol 81, 4348–4356.[CrossRef] [Google Scholar]
  29. Liang, H., Petros, A. M., Meadows, R. P., Yoon, H. S., Egan, D. A., Walter, K., Holzman, T. F., Robins, T. & Fesik, S. W.(1996). Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions. Biochemistry 35, 2095–2103.[CrossRef] [Google Scholar]
  30. Lieberman, P. M., Hu, J. & Renne, R.(2007). Gammaherpesvirus maintenance and replication during latency. In Human Herpesvirus: Biology. Therapy and Immunoprophylaxis, pp. 379–402. Edited by A. Arvin, G. Campadelli-Fiume, E. Mocarski, P. S. Moore, B. Roizman, R. Whitley and K. Yamanishi. New York: Cambridge University Press.
  31. Lim, C., Sohn, H., Lee, D., Gwack, Y. & Choe, J.(2002). Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J Virol 76, 10320–10331.[CrossRef] [Google Scholar]
  32. Moss, B., Elroy-Stein, O., Mizukami, T., Alexander, W. A. & Fuerst, T. R.(1990). Product review. New mammalian expression vectors. Nature 348, 91–92.[CrossRef] [Google Scholar]
  33. Notredame, C., Higgins, D. G. & Heringa, J.(2000). T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302, 205–217.[CrossRef] [Google Scholar]
  34. Pierce, B., Tong, W. & Weng, Z.(2005).m-zdock: a grid-based approach for Cn symmetric multimer docking. Bioinformatics 21, 1472–1478.[CrossRef] [Google Scholar]
  35. Pierce, B., Tong, W. & Weng, Z.(2007).zrank: reranking protein docking predictions with an optimized energy function. Proteins 67, 1078–1086.[CrossRef] [Google Scholar]
  36. Pirovano, W. & Heringa, J.(2010). Protein secondary structure prediction. Methods Mol Biol 609, 327–348. [Google Scholar]
  37. Purta, E., van Vliet, F., Tricot, C., De Bie, L. G., Feder, M., Skowronek, K., Droogmans, L. & Bujnicki, J. M.(2005). Sequence–structure–function relationships of a tRNA (m7G46) methyltransferase studied by homology modeling and site-directed mutagenesis. Proteins 59, 482–488.[CrossRef] [Google Scholar]
  38. Renne, R., Barry, C., Dittmer, D., Compitello, N., Brown, P. O. & Ganem, D.(2001). Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75, 458–468.[CrossRef] [Google Scholar]
  39. Sambrook, J. & Russell, D. W. (eds)(2001).Molecular Cloning: a Laboratory Manual, 3rd edn. New York: Cold Spring Harbor Laboratory Press.
  40. Schepers, A., Ritzi, M., Bousset, K., Kremmer, E., Yates, J. L., Harwood, J., Diffley, J. F. & Hammerschmidt, W.(2001). Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein–Barr virus. EMBO J 20, 4588–4602.[CrossRef] [Google Scholar]
  41. Schwam, D. R., Luciano, R. L., Mahajan, S. S., Wong, L. & Wilson, A. C.(2000). Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. J Virol 74, 8532–8540.[CrossRef] [Google Scholar]
  42. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M. F., Clauvel, J. P., Raphael, M. & Degos, L.(1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276–1280. [Google Scholar]
  43. Stedman, W., Deng, Z., Lu, F. & Lieberman, P. M.(2004). ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol 78, 12566–12575.[CrossRef] [Google Scholar]
  44. Verma, S. C., Choudhuri, T., Kaul, R. & Robertson, E. S.(2006). Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J Virol 80, 2243–2256.[CrossRef] [Google Scholar]
  45. Verma, S. C., Lan, K. & Robertson, E.(2007). Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol 312, 101–136. [Google Scholar]
  46. Wong, L. Y. & Wilson, A. C.(2005). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA. J Virol 79, 13829–13836.[CrossRef] [Google Scholar]
  47. You, J., Srinivasan, V., Denis, G. V., Harrington, W. J., Jr, Ballestas, M. E., Kaye, K. M. & Howley, P. M.(2006). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J Virol 80, 8909–8919.[CrossRef] [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.020958-0
Loading
Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins
J. Gen. Virol. 91, 2203 (2010); https://doi.org/10.1099/vir.0.020958-0
/content/journal/jgv/10.1099/vir.0.020958-0
/content/journal/jgv/10.1099/vir.0.020958-0
Loading

Data & Media loading...

Supplements

vol. , part 9, pp. 2203 - 2215

Western blot analysis of purified wt and mutant LANADBD proteins

Oligonucleotide primers used to generate amino acid substitution mutants [Single PDF file](117 KB)

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error